Loading…
Loading…
Lilly(Eli) & Company
NYSE · Stock Profile · Market Cap $867.91B
Current Price
$918.05
-1.32%GoodMoat Value
$419.58
54.3% overvaluedProfit margin of 31.7% — that's well above average.
Forward estimates use 50.0% FCF growth (CAGR)
Net Debt: 35.2B
11.3B
FY24
11.4B
FY24
45.0B
FY24
12.7B
FY25
15.6B
FY25
17.6B
FY25
65.2B
FY25
3.0B
FY24
970M
FY24
10.6B
FY24
2.8B
FY25
5.7B
FY25
5.6B
FY25
20.6B
FY25
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
Indiana, USA
Price sits at 61% of its 52-week range.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
0.65%
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
Indiana, USA